Radu Marcheş

3.0k total citations · 1 hit paper
32 papers, 1.6k citations indexed

About

Radu Marcheş is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Radu Marcheş has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 12 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Radu Marcheş's work include Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Radu Marcheş is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Radu Marcheş collaborates with scholars based in United States, Netherlands and Argentina. Radu Marcheş's co-authors include Ellen S. Vitetta, Jonathan W. Uhr, Duygu Ucar, Jacques Banchereau, Cheng‐Han Chung, George A. Kuchel, Robert J. Rossi, Paul Pantano, Eladio J. Márquez and Rockford K. Draper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Radu Marcheş

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sexual-dimorphism in human immune system aging

2020 342 citations Eladio J. Márquez, Cheng‐Han Chung et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Radu Marcheş United States	20	531	461	428	318	233	32	1.6k
Xiaopeng Ma China	24	663 1.2×	476 1.0×	310 0.7×	513 1.6×	204 0.9×	128	2.0k
Teresa K. Tarrant United States	24	482 0.9×	837 1.8×	296 0.7×	308 1.0×	318 1.4×	67	2.1k
Suet‐Mien Tan Singapore	23	806 1.5×	622 1.3×	129 0.3×	238 0.7×	208 0.9×	66	2.1k
Samantha Stewart United States	22	518 1.0×	322 0.7×	442 1.0×	247 0.8×	49 0.2×	48	1.6k
Jingwu Zhang United States	26	663 1.2×	1.0k 2.3×	266 0.6×	194 0.6×	91 0.4×	55	2.2k
Hélène Dumortier France	24	382 0.7×	799 1.7×	268 0.6×	509 1.6×	461 2.0×	46	1.9k
Yoshiaki Yura Japan	28	1.0k 1.9×	283 0.6×	568 1.3×	141 0.4×	153 0.7×	172	2.7k
Per Björk Sweden	23	971 1.8×	527 1.1×	195 0.5×	105 0.3×	146 0.6×	57	1.8k
Jianwei Zhu China	28	1.3k 2.5×	490 1.1×	497 1.2×	204 0.6×	140 0.6×	120	2.4k

Countries citing papers authored by Radu Marcheş

Since Specialization

Citations

This map shows the geographic impact of Radu Marcheş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radu Marcheş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radu Marcheş more than expected).

Fields of papers citing papers by Radu Marcheş

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radu Marcheş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radu Marcheş. The network helps show where Radu Marcheş may publish in the future.

Co-authorship network of co-authors of Radu Marcheş

This figure shows the co-authorship network connecting the top 25 collaborators of Radu Marcheş. A scholar is included among the top collaborators of Radu Marcheş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radu Marcheş. Radu Marcheş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nehar-Belaid, Djamel, Asunción Mejías, Zhaohui Xu, et al.. (2025). SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses. Nature Communications. 16(1). 4562–4562. 2 indexed citations

Johnson, Michael, Debashis Ghosh, Radu Marcheş, et al.. (2025). The recombinant zoster vaccine induces trained immunity in monocytes through persistent downregulation of TGFβ. PLoS Pathogens. 21(12). e1013759–e1013759. 1 indexed citations

Díaz, Fernando Erra, Emin Onur Karakaslar, Radu Marcheş, et al.. (2024). Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults. Nature Immunology. 25(2). 316–329. 12 indexed citations

Caielli, Simone, Preetha Balasubramanian, Juan F. Rodríguez-Alcázar, et al.. (2024). Type I IFN drives unconventional IL-1β secretion in lupus monocytes. Immunity. 57(11). 2497–2513.e12. 15 indexed citations

Karakaslar, Emin Onur, Neerja Katiyar, Muneer G. Hasham, et al.. (2023). Transcriptional activation of Jun and Fos members of the AP‐1 complex is a conserved signature of immune aging that contributes to inflammaging. Aging Cell. 22(4). e13792–e13792. 45 indexed citations

George, Parakkal Jovvian, Radu Marcheş, Djamel Nehar-Belaid, Jacques Banchereau, & Sara Lustigman. (2022). The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways. Frontiers in Immunology. 13. 961094–961094. 2 indexed citations

Thibodeau, Asa, Alper Eroğlu, Christopher S. McGinnis, et al.. (2021). AMULET: a novel read count-based method for effective multiplet detection from single nucleus ATAC-seq data. Genome biology. 22(1). 252–252. 35 indexed citations

Márquez, Eladio J., Cheng‐Han Chung, Radu Marcheş, et al.. (2020). Sexual-dimorphism in human immune system aging. Nature Communications. 11(1). 751–751. 342 indexed citations breakdown →

Ucar, Duygu, Eladio J. Márquez, Cheng‐Han Chung, et al.. (2017). The chromatin accessibility signature of human immune aging stems from CD8+ T cells. The Journal of Experimental Medicine. 214(10). 3123–3144. 146 indexed citations

10.

Marcheş, Radu, et al.. (2011). The importance of cellular internalization of antibody-targeted carbon nanotubes in the photothermal ablation of breast cancer cells. Nanotechnology. 22(9). 95101–95101. 55 indexed citations

11.

Marcheş, Radu, Inga H. Musselman, Pooja Bajaj, et al.. (2009). Specific thermal ablation of tumor cells using single‐walled carbon nanotubes targeted by covalently‐coupled monoclonal antibodies. International Journal of Cancer. 125(12). 2970–2977. 42 indexed citations

12.

Fehm, Tanja, Volkmar Mueller, Radu Marcheş, et al.. (2008). Tumor cell dormancy: implications for the biology and treatment of breast cancer. Apmis. 116(7-8). 742–753. 31 indexed citations

13.

Marcheş, Radu, Richard H. Scheuermann, & JW Uhr. (2006). Cancer Dormancy from Mice to Man: A Review. Cell Cycle. 5(16). 1772–1778. 44 indexed citations

14.

Alarcón, Tomás, Radu Marcheş, & Karen M. Page. (2005). Mathematical models of the fate of lymphoma B cells after antigen receptor ligation with specific antibodies. Journal of Theoretical Biology. 240(1). 54–71. 6 indexed citations

15.

Marcheş, Radu & Jonathan W. Uhr. (2004). Enhancement of the p27^Kip1‐mediated antiproliferative effect of trastuzumab (Herceptin) on HER2‐overexpressing tumor cells. International Journal of Cancer. 112(3). 492–501. 38 indexed citations

16.

Uhr, Jonathan W., et al.. (2002). Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.. PubMed. 8(6). 1720–30. 138 indexed citations

17.

Uhr, Jonathan W. & Radu Marcheş. (2001). Dormancy in a model of murine B cell lymphoma. Seminars in Cancer Biology. 11(4). 277–283. 35 indexed citations

18.

Hsueh, Robert C., Adrienne M. Hammill, Radu Marcheş, J W Uhr, & Richard H. Scheuermann. (1999). Antigen Receptor Signaling Induces Differential Tyrosine Kinase Activation and Population Stability in B-Cell Lymphoma. Current topics in microbiology and immunology. 246. 299–305. 5 indexed citations

19.

Uhr, Jonathan W., Radu Marcheş, Emilian Racila, et al.. (1996). Role of Antibody Signaling in Inducing Tumor Dormancy. Advances in experimental medicine and biology. 406. 69–74. 8 indexed citations

20.

Racila, Emilian, Richard H. Scheuermann, Louis J. Picker, et al.. (1995). Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice.. The Journal of Experimental Medicine. 181(4). 1539–1550. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact